Cited by 1,291Genetic Neurodegenerative DiseasesPrion Diseases and Protein MisfoldingGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo

Open access

Scherzinger, Eberhard, Lurz, Rudi, Turmaine, Mark, Mangiarini, Laura, Hollenbach, Birgit, Hasenbank, Renate, Bates, Gillian P, Davies, Stephen W, Lehrach, Hans, Wanker, Erich E·1997·Cell

DOI 10.1016/s0092-8674(00)80514-0

Open this paper in CoChat — free account Open PDF

Abstract

The mechanism by which an elongated polyglutamine sequence causes neurodegeneration in Huntington's disease (HD) is unknown. In this study, we show that the proteolytic cleavage of a GST-huntingtin fusion protein leads to the formation of insoluble high molecular weight protein aggregates only when the polyglutamine expansion is in the pathogenic range. Electron micrographs of these aggregates revealed a fibrillar or ribbon-like morphology, reminiscent of scrapie prions and beta-amyloid fibrils in Alzheimer's disease. Subcellular fractionation and ultrastructural techniques showed the in vivo presence of these structures in the brains of mice transgenic for the HD mutation. Our in vitro model will aid in an eventual understanding of the molecular pathology of HD and the development of preventative strategies.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)80514-0

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citation
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188
Self-citation
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
Perutz, M. F., Johnson, T., Suzuki, M., & Finch, J. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5355 · Cited by 1,060
Scrapie prions aggregate to form amyloid-like birefringent rods
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D., & Glenner, G. G. (1983) · Cell · doi:10.1016/0092-8674(83)90168-x · Cited by 1,052

Show all 42 references

Research works printed but not linked: 2

Harper, P.S. (1991). Huntington's disease, Edition 22. P.S. Harper, ed. (London: W.B. Saunders Co., Ltd).
Roizin, 1979, Neuronal nuclear-cytoplasmic changes in Huntington's chorea, Adv. Neurol., 23, 95

Sorted by citations

Items 901–998 of 998

Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high‐capacity adenoviral vectors expressing truncated and full‐length huntingtin with polyglutamine expansion
Huang, B., Schiefer, J., Saß, C., Kosinski, C. M., & Kochanek, S. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1150 · Cited by 12
Huntington Disease
Wagner, L. A., Menalled, L., Goumeniouk, A. D., Brunner, D., & Leavitt, B. R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00018-7 · Cited by 12
Pathogenesis of polyglutamine-induced disease: A model for SCA1.
Klement, I., Zoghbi, H., & Orr, H. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2801 · Cited by 15
Subcellular localization of the Alzheimer's disease amyloid precursor protein and derived polypeptides expressed in a recombinant yeast system
Culvenor, J. G., Henry, A., Hartmann, T., Evin, G. M., Galatis, D., Friedhuber, A. M., Jayasena, R., Underwood, J. R., Beyreuther, K. T., Masters, C. L., et al. (1998) · Amyloid · doi:10.3109/13506129808995285 · Cited by 12
Genetic Aberrancies and Neurodegenerative Disorders
(1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)x6002-x · Cited by 12
Global proteome metastability response in isogenic animals to missense mutations and polyglutamine expansions in agingPreprint
Sui, X., Prado, M. A., Paulo, J. A., Gygi, S. P., Finley, D. J., & Morimoto, R. I. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.28.509812 · Cited by 10
Pathobiology of the autophagy-lysosomal pathway in the Huntington’s disease brainPreprint
Berg, M. J., Veeranna, Rosa, C. M., Kumar, A. R., Mohan, P. S., Stavrides, P. H., Marchionini, D. M., Yang, D., & Nixon, R. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.29.596470 · Cited by 12
Artificial enforcement of the unfolded protein response reduces disease features in multiple preclinical models of ALS/FTD
Valenzuela, V., Becerra, D., Astorga, J. I., Fuentealba, M., Diaz, G., Bargsted, L., Chacón, C., Martinez, A. N., Gozalvo, R., Jackson, K. L., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.004 · Cited by 11
Molecular Origin of Gerstmann-Sträussler-Scheinker Syndrome: Insight from Computer Simulation of an Amyloidogenic Prion Peptide
Daidone, I., Nola, A. D., & Smith, J. C. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.04.053 · Cited by 11
“There is a considerable interest in understanding the molecular mechanisms of misfolding in prion and other amyloid diseases, such as Alzheimer’s, Huntington’s, and Parkinson’s (1,45–47) and there is hope that this understanding might eventually lead to new therapies for these illnesses.”
Background
Fluorogenic detection of protein aggregates in live cells using the AggTag method
Jung, K. H., & Zhang, X. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2020.04.006 · Cited by 11
Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease
Shin, J. W., Shin, A., Park, S. S., & Lee, J. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.03.001 · Cited by 11
Mega assemblages of oligomeric aerolysin-like toxins stabilized by toxin-associating membrane proteins
Shimada, H., & Kitada, S. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq124 · Cited by 11
Covalent Structural Changes in Unfolded GroES That Lead to Amyloid Fibril Formation Detected by NMR
Iwasa, H., Meshitsuka, S., Hongo, K., Mizobata, T., & Kawata, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228445 · Cited by 11
Filter Retardation Assay for Detecting and Quantifying Polyglutamine Aggregates Using Caenorhabditis elegans Lysates
Sin, O., Mata‐Cabana, A., Seinstra, R. I., & Nollen, E. A. A. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3042 · Cited by 10
“Filter retardation assay is a quick and sensitive method that detects and quantifies protein aggregates formed in vivo and in vitro, including polyglutamine (Scherzinger et al., 1997; Wanker et al., 1999), alpha-synuclein (Recasens et al., 2018), and amyloid-beta aggregates (Bieschke et al., 2009).”
Method
Stable Polyglutamine Dimers Can Contain β-Hairpins with Interdigitated Side Chains—But Not α-Helices, β-Nanotubes, β-Pseudohelices, or Steric Zippers
Miettinen, M. S., Monticelli, L., Nedumpully-Govindan, P., Knecht, V., & Ignatova, Z. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.02.027 · Cited by 11
In reverse gear
Bates, G. P. (2000) · Nature · doi:10.1038/35010254 · Cited by 11
Self-citation
Involvement of polyglutamine endolysis followed by pyroglutamate formation in the pathogenesis of triplet repeat/polyglutamine-expansion diseases
Saido, T. C. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0866 · Cited by 11
Characterization of the Mouse Src Homology 3 Domain GeneSh3d2con Chr 7 Demonstrates Coexpression with Huntingtin in the Brain and Identifies the Processed PseudogeneSh3d2c-ps1on Chr 2
Zechner, U., Scheel, S., Hemberger, M., Hopp, M., Haaf, T., Fundele, R. H., Wanker, E. E., Lehrach, H. R., Wedemeyer, N., & Himmelbauer, H. (1998) · Genomics · doi:10.1006/geno.1998.5584 · Cited by 11
Self-citation
Gene-environment interplay in neurogenesis and neurodegeneration
Palomo, T., Archer, T., Beninger, R. J., & Kostrzewa, R. M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033279 · Cited by 11
“Structural determinations and aggregations of the mutant htt protein (cf. Perutz, 1994; Scherzinger et al., 1997; 1999: Yu et al., 2003), as well as brain pathology determination of HD patients and transgenic mice expressing mutant htt protein, show the htt immunoreactive aggregates in nuclei of…”
Background
Delayed protein translocation protects mitochondria against toxic CAT-tailed proteins
Bertram, N., Izawa, T., Thoma, F., Schwenkert, S., Duvezin‐Caubet, S., Park, S.-H., Wagener, N., Devin, A., Osman, C., Neupert, W., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.09.030 · Cited by 10
The Effect of Octapeptide Repeats on Prion Folding and Misfolding
Yu, K.-H., Huang, M., Lee, Y.-R., Lin, Y.-K., Chen, H., & Lee, C.-I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041800 · Cited by 10
“Huntington’s disease has also been ascribed to misfolding of huntingtin protein caused by an increase of polyglutamine [29].”
Background
Experimental Models for Identifying Modifiers of Polyglutamine-Induced Aggregation and Neurodegeneration
Calamini, B., Lo, D. C., & Kaltenbach, L. S. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0195-4 · Cited by 9
Cellular Models: HD Patient-Derived Pluripotent Stem Cells
Smith-Geater, C., Hernandez, S. J., Thompson, L. M., & Mattis, V. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_4 · Cited by 10
Targeting N-type calcium channels in young-onset of some neurological diseases
Antunes, F. T. T., de Souza, A. H., Figueira, J., Binda, N. S., Carvalho, V. P. R., Vieira, L. B., & Gomez, M. V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1090765 · Cited by 10
“It results in the production of a long polyglutamine (PolyQ) fragment in the Huntingtin protein (HTT), inhibiting its activity, or merging into the mutant huntingtin (mHTT) aggregates (Scherzinger et al., 1997).”
Background
Mouvements anormaux (dystonie, athétose, chorée, ballisme)
Vingerhoets, F., Rüssmann, H.-J., Carruzzo, A., Combremont, P., & Ghika, J. A. (2004) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/j.emcn.2003.10.006 · Cited by 10
“[94] On a retrouvé des corps d’inclusions composés du fragment « N-terminal » de la protéine mutante dans les noyaux neuronaux au niveau cortical et striatal.”
The yan gene is highly conserved in Drosophila and its expression suggests a complex role throughout development
Price, M., & Lai, Z. C. (1999) · Development Genes and Evolution · doi:10.1007/s004270050245 · Cited by 10
“(Campos et al. 1987; Bender et al. 1988; Scherzinger et al. 1997 ).”
N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function
Schiffer, N. W., Céraline, J., Hartl, F. U., & Broadley, S. A. (2008) · Biological Chemistry · doi:10.1515/bc.2008.169 · Cited by 11
“For the filter trap assay (Scherzinger et al., 1997), an equal volume of 4% SDS/100 mM dithiothreitol (DTT) was added to extracts, where indicated, and the mixture was heated for 3 min at 958C.”
BackgroundMethod
Engineering a membrane protein chaperone to ameliorate the proteotoxicity of mutant huntingtin
Oh, J. H., Catherine, C., Kim, E. S., Min, K. W., Jeong, H. C., Kim, H., Kim, M., Ahn, S. H., Lukianenko, N., Jo, M. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56030-6 · Cited by 9
Application and expression of Toxoplasma gondii surface antigen 2 (SAG2) and rhoptry protein 2 (ROP2) from recombinant Escherichia coli strain
Yan, H., Yan, H., Tao, Y., Chen, H., Li, G., Gong, W., Jiao, H., Tian, F., & Ming-chun, J. (2012) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2012.02.008 · Cited by 9
Molecular mechanics and all-electron fragment molecular orbital calculations on mutated polyglutamine peptides
Schouwen, B. M. B. V., Nakano, M., Watanabe, H., Tanaka, S., Gordon, H. L., & Rothstein, S. M. (2009) · Journal of Molecular Structure THEOCHEM · doi:10.1016/j.theochem.2009.12.019 · Cited by 9
Hypoxia-inducible factor-1α in Antarctic notothenioids contains a polyglutamine and glutamic acid insert that varies in length with phylogeny
Rix, A. S., Grove, T. J., & O’Brien, K. M. (2017) · Polar Biology · doi:10.1007/s00300-017-2164-6 · Cited by 9
“number of polyQ repeats leads to earlier onset of the disease and a more severe phenotype (Scherzinger et al. 1997).”
Does N‐terminal huntingtin function as a ‘holdase’ for inhibiting cellular protein aggregation?
Sethi, R., Tripathi, N., Pallapati, A., Gaikar, A., Bharatam, P. V., & Roy, I. (2018) · FEBS Journal · doi:10.1111/febs.14457 · Cited by 9
Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington’s disease
Li, E., Park, H. R., Hong, C. P., Kim, Y.-H., Choi, J., Lee, S., Park, H. J., Lee, B., Kim, T. A., Kim, S.-J., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12893 · Cited by 8
Lysine245 plays a crucial role in stability and function of glycerol 3‐phosphate dehydrogenase (Gpd1) in Saccharomyces cerevisiae
Pallapati, A., Sirigiri, S. D., Jain, S., Ratnala, V., & Roy, I. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30125 · Cited by 9
“Cellulose acetate retains aggregates while allowing monomeric proteins to pass through.(22,29) The intensity of the dots indicated the aggregation of EGFP tagged wGpd1 and mGpd1 (Figure 2B).”
Saccharomyces cerevisiae Fpr1 functions as a chaperone to inhibit protein aggregation
Das, E., Prasad, S., & Roy, I. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.046 · Cited by 8
The Heat Shock Response and the Stress of Misfolded Proteins
Morimoto, R. I., & Westerheide, S. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00268-0 · Cited by 9
Physiopathologie de la maladie de Huntington : état des connaissances
Roze, E. F., Bétuing, S., Deyts, C., Vidailhet, M., & Caboche, J. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.03.006 · Cited by 11
The Phosphorylation of the Heat Shock Factor as a Modulator for the Heat Shock Response
Czeizler, E., Rogojin, V., & Petre, I. (2012) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2012.66 · Cited by 9
Patterns of [PSI+] aggregation allow insights into cellular organization of yeast prion aggregates
Tyedmers, J. (2012) · Prion · doi:10.4161/pri.18986 · Cited by 9
Ubiquitin-interacting Motifs Inhibit Aggregation of PolyQ-expanded Huntingtin
Miller, S. L., Scappini, E., & O’Bryan, J. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611151200 · Cited by 9
A flexible polyglutamine hinge opens new doors for understanding huntingtin function
Giorgini, F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313668110 · Cited by 9
The hnRNP-like Nab3 termination factor can employ heterologous prion-like domains in place of its own essential low complexity domain
Loya, T. J., O’Rourke, T. W., & Reines, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186187 · Cited by 9
31P and 13C solid-state NMR analysis of morphological changes of phospholipid bilayers containing glucagon during fibril formation of glucagon under neutral condition
Kazumi, H., Makino, Y., Kikuchi-Kinoshita, A., Kawamura, I., & Naito, A. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183290 · Cited by 9
Identification of five Spinocerebellar Ataxia Type 2 pedigrees in patients with autosomal dominant cerebellar ataxia in Taiwan
Hsieh, M., Li, S.-Y., Tsai, C., Chen, Y.-C., Liu, C. S., Chan, C.-Y., Ro, L. ‐., Chen, D.-F., Chen, S.-S., & Li, C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00737.x · Cited by 9
Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro
Calabresi, V., Guida, S., Servadio, A., & Jodice, C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00600-1 · Cited by 9
“2 m pore size), using a BRL dot blot filtration unit [14].”
BackgroundMethodInfluential
Protein Folding and Aggregation in the Expanded Polyglutamine Repeat Diseases
Wetzel, R. (2008) · Protein Science Encyclopedia · doi:10.1002/9783527610754.md11 · Cited by 8
The Use of MicroPET for the Development of Neural Repair Therapeutics: Studies in Epilepsy and Lesion Models
Kornblum, H. I., & Cherry, S. R. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/0091270001417009 · Cited by 9
Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid β-peptides
Larner, A. J., & Rossor, M. N. (1997) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.7.10.1115 · Cited by 9
Direct Observation of Secondary Nucleation in Huntingtin Amyloid Formation by High-Speed Atomic Force Microscopy
van Ewijk, C., Jain, G., Knelissen, Y. K., Maity, S., van der Wel, P. C. A., & Roos, W. H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c05571 · Cited by 8
Pathogenesis of polyglutamine diseases: Piecing together a complex molecular puzzle
Gonzalez, E. V., & Zoghbi, H. Y. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241336 · Cited by 11
Selective targeting of mutant huntingtin intron 1 improves rescue provided by antisense oligonucleotides in Huntington’s disease mice
Bragg, R. M., Landles, C., Smith, E. J., Osborne, G. F., Mathews, E. W., Cantle, J. P., Bates, G. P., & Carroll, J. B. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adv0702 · Cited by 11
Self-citation
Cell-free analysis of polyQ-dependent protein aggregation and its inhibition by chaperone proteins
Machida, K., Shigeta, T., Kobayashi, A., Masumoto, A., Hidaka, Y., & Imataka, H. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.09.031 · Cited by 8
Eumelanin fibrils
McQueenie, R., Sutter, J. U., Karolin, J. O., & Birch, D. J. S. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.17.7.075001 · Cited by 8
Highly Potent Peptide Therapeutics To Prevent Protein Aggregation in Huntington’s Disease
Khan, A., Özçelik, C. E., Beğli, Ö., Oğuz, O., Kesici, M. S., Kasırga, T. S., Özçubukçu, S., Yuca, E., & Şeker, U. Ö. Ş. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00415 · Cited by 8
Stem Cell Therapy for Neurodegenerative Diseases: Strategies for Regeneration against Degeneration
Mirahmadi, M., Rezanejadbardaji, H., Irfan‐Maqsood, M., Mokhtari, M. J., & Naderi‐Meshkin, H. (2017) · Journal of Genes and Cells · doi:10.15562/gnc.54 · Cited by 8
“Many of neurodegenerative diseases are characterized by the accumulation of disease- specific misfolded proteins in the CNS (23, 115, 116).”
BackgroundInfluential
Huntingtin Polyglutamine-Dependent Protein Aggregation in Reconstituted Cells
Machida, K., Kanzawa, K., Shigeta, T., Yamamoto, Y., Tsumoto, K., & Imataka, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00372 · Cited by 8
A Filter Retardation Assay Facilitates the Detection and Quantification of Heat-Stable, Amyloidogenic Mutant Huntingtin Aggregates in Complex Biosamples
Ast, A., Schindler, F., Buntru, A., Schnoegl, S., & Wanker, E. E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_3 · Cited by 8
Self-citation
Pollutants corrupt resilience pathways of aging in the nematode C. elegans
Scharf, A., Limke, A., Guehrs, K.-H., & von Mikecz, A. H. (2022) · iScience · doi:10.1016/j.isci.2022.105027 · Cited by 8
“To now characterize the iHg-induced aggregation network in order to compare the components to the silica NPs-induced aggregome network, wild-type day 1 adults were either left untreated (H2O) or treated with 50 μM iHg for 24 hours, lysed, and the SDS-insoluble protein fraction isolated via filter retardation assay (Sc…”
MethodInfluential
Selective observation of semi-rigid non-core residues in dynamically complex mutant huntingtin protein fibrils
Matlahov, I., Boatz, J. C., & van der Wel, P. C. A. (2022) · Journal of Structural Biology X · doi:10.1016/j.yjsbx.2022.100077 · Cited by 8
“Notably, the mutation behind HD involves the genetic expansion of the HttEx1 polyglutamine (polyQ) domain, as illustrated in Figure 1 (Scherzinger et al., 1997).”
Background
Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
Hoffner, G., André, W., Vanhoutteghem, A., Souès, S., & Djian, P. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012107 · Cited by 8
Discrete roles of trehalose and Hsp104 in inhibition of protein aggregation in yeast cells
Sethi, R., Iyer, S. S., Das, E., & Roy, I. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy058 · Cited by 8
Mouvements anormaux (dystonie, athétose, chorée, ballisme)
Vingerhoets, F., Rüssmann, H.-J., Carruzzo, A., Combremont, P., & Ghika, J. A. (2004) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(04)75776-0 · Cited by 8
Trinucleotide Repeat Protocols
(2013) · Methods in molecular biology · doi:10.1007/978-1-62703-411-1 · Cited by 8
Chemical and Physical Properties of Polyglutamine Repeat Sequences
Wetzel, R. B. (2006) · Elsevier eBooks · doi:10.1016/b978-012369462-1/50035-1 · Cited by 8
Impairment of lysosomal quality control in Huntington disease
Rusmini, P., Mina, F., Valenza, M., Vitali, M., Ferrari, V., Tedesco, B., Casarotto, E., Cozzi, M., Chierichetti, M., Mohamed, A., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08103-z · Cited by 7
“…are partially unclear; several hypotheses have been proposed, highlighting different states with oligomers formation and amorphous aggregates [63 – 67]; in addition, the increased length of the polyQ tract directly correlates with the nature of the inclusions, where the longer polyQ tracts…”
Pathogenic TDP ‐43 accelerates the generation of toxic exon1 HTT in Huntington's disease knock‐in mice
Bai, D., Deng, F., Jia, Q., Ou, K., Wang, X., Hou, J., Zhu, L., Guo, M., Yang, S., Jiang, G., et al. (2024) · Aging Cell · doi:10.1111/acel.14325 · Cited by 6
“Although the truncated mutant Htt-exon1 band was also illustrated in many previous reports (Mangiarini et al., 1996; Neueder et al., 2017; Sathasivam et al., 2013; Scherzinger et al., 1997), it remains to be verified that this band represents exon1 Htt.”
The Classifying Autoencoder: Gaining Insight into Amyloid Assembly of Peptides and Proteins
Jhatro, M., Charest, N., Taitz, Z., Shea, J., & Bowers, M. T. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b03415 · Cited by 7
Spinocerebellar Ataxia Type 3: A Case Report and Literature Review
McCord, M., Bigio, E. H., Kam, K. L., Fischer, V., Obeidin, F., White, C. L., Brat, D. J., Müller, W. A., & Mao, Q. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa033 · Cited by 7
Charge within Nt17 peptides modulates huntingtin aggregation and initial lipid binding events
Stonebraker, A. R., Hankin, R., Kapp, K. L., Li, P., Valentine, S. J., & Legleiter, J. A. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107123 · Cited by 8
Expansion of the polyQ repeats in THAP11 forms intranuclear aggregation and causes cell G0/G1 arrest
Yin, R., Li, Y., Yang, F., Zhan, Y., Yu, M., Ge, C., Xu, W., Tang, L., Wang, X., Chen, B., et al. (2014) · Cell Biology International · doi:10.1002/cbin.10255 · Cited by 7
“PolyQs aggregate in vitro, and the threshold length for in vitro aggregation correlates with the pathogenic repeat length threshold (Scherzinger et al., 1997).”
Background
Mutation effects on structural stability of polyglutamine peptides by molecular dynamics simulation
Nakano, M., Watanabe, H., STARIKOV, E. B., Rothstein, S. M., & Tanaka, S. (2009) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-008-0020-7 · Cited by 7
Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis
Cong, S., Pepers, B. A., Roos, R. A. C., van Ommen, G. B., & Dorsman, J. C. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.11.008 · Cited by 7
Modeling Protein Aggregate Assembly and Structure
Guo, J., Hall, C. K., Xu, Y., & Wetzel, R. B. (2007) · Springer eBooks · doi:10.1007/978-0-387-68372-0_9 · Cited by 7
Nascent mutant Huntingtin exon 1 chains do not stall on ribosomes during translation but aggregates do recruit machinery involved in ribosome quality control and RNA
Ormsby, A. R., Cox, D., Daly, J. C., Priest, D., Hinde, E., & Hatters, D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233583 · Cited by 7
Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
Higgins, N. R., Greenslade, J. E., Wu, J. J., Miranda, E., Galliciotti, G., & Monteiro, M. J. (2021) · Brain Pathology · doi:10.1111/bpa.12948 · Cited by 8
“In this assay, protein aggregates that are too large to pass through the pores of a 0.2 μm cellulose acetate membrane under vacuum filtration are retained and their amount can be quantified by antibody reactivity (35, 53).”
Influential
One‐Pot Semisynthesis of Exon 1 of the Huntingtin Protein: New Tools for Elucidating the Role of Posttranslational Modifications in the Pathogenesis of Huntington’s Disease
Ansaloni, A., Wang, Z., Jeong, J. S., Ruggeri, F. S., Dietler, G., & Lashuel, H. A. (2014) · Angewandte Chemie · doi:10.1002/ange.201307510 · Cited by 7
Swapping the Positions in a Cross-Strand Lateral Ion-Pairing Interaction between Ammonium- and Carboxylate-Containing Residues in a β-Hairpin
Huang, C., Wong, T. W., Yu, C., Chang, J., Huang, S., Huang, S., & Cheng, R. P. (2021) · Molecules · doi:10.3390/molecules26051346 · Cited by 7
“Furthermore, β -sheets are also formed in amyloid ﬁbrils involved in various diseases, including Alzheimer’s disease [4,5], Huntington’s disease [6], and Parkinson’s disease [7,8].”
Of mice and men: solving the molecular mysteries of Huntington's disease
Shelbourne, P. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640617.x · Cited by 7
“In vitro studies subsequently confirmed that proteolytic cleavage of huntingtin protein containing 51 glutamine repeats resulted in the formation of highly ordered structures reminiscent of amyloid fibrils (Scherzinger et al. 1997).”
Background
Misfolding and Aggregation in Huntington Disease and Other Expanded Polyglutamine Repeat Diseases
Wetzel, R. B. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch14 · Cited by 7
Molecular Chaperones and the Ubiquitin–Proteasome System
Patterson, C., & Höhfeld, J. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch1a · Cited by 7
Molecular Basis of Genetic Heterogeneity: Role of the Clinical Neurologist
Rowland, L. P. (1998) · Journal of Child Neurology · doi:10.1177/088307389801300306 · Cited by 7
Circumvention of Chaperone Requirement for Aggregate Formation of a Short Polyglutamine Tract by the Co-expression of a Long Polyglutamine Tract
Kimura, Y., Koitabashi, S., Kakizuka, A., & Fujita, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201721200 · Cited by 7
The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
Cho, H.-J. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1527313 · Cited by 7
Molecular basis of Huntington's disease and brain imaging evidence
Plerou, A., Bobori, C., & Vlamos, P. (2015) · IEEE International Symposium on Signal Processing and Information Technology (ISSPIT) · doi:10.1109/isspit.2015.7394365 · Cited by 6
Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity
Tsai, T.-Y., Chen, C., Lin, T.-W., Lin, T.-C., Chiu, F., Shih, O., Chang, M., Lin, Y., Su, A., Chen, C., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05142-0 · Cited by 6
“Mutant Htts with more than 35 – 40 glutamine residues are prone to misfold and form amyloid ﬁ brils that ultimately deposit as inclusions in the nucleus and cytoplasm of neurons, resulting in neuronal loss and progressive brain dysfunction 3 – 6 .”
A Specific Mini‐Intrabody Mediates Lysosome Degradation of Mutant Huntingtin
Li, C., Lin, Y., Chen, Y., Song, X., Zheng, X., Li, J., He, J., Chen, X., Huang, C., Wang, W., et al. (2023) · Advanced Science · doi:10.1002/advs.202301120 · Cited by 6
Length of polyglutamine tract affects secondary and tertiary structures of huntingtin protein
Vachharajani, S., Chaudhary, R. K., Prasad, S., & Roy, I. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.07.022 · Cited by 6
Structure propensities in mutated polyglutamine peptides
VanSchouwen, B., Oblinsky, D. G., Gordon, H. L., & Rothstein, S. M. (2011) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-011-0058-9 · Cited by 6
“It is characterized by behaviour problems, personality changes and dementia that typically begin in midadulthood, and results in death within a few years of onset (Hodgson et al., 1999; Rubinsztein et al., 1996; Scherzinger et al., 1997).”
Background
A novel mitochondrial tRNAAla gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease
Filosto, M., Lanzi, G., Nesti, C., Vielmi, V., Marchina, E., Galvagni, A., Giliani, S. C., Santorelli, F. M., & Padovani, A. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.02.001 · Cited by 6
Mapping the contact surfaces in the Lamin A:AIMP3 complex by hydrogen/deuterium exchange FT-ICR mass spectrometry
Tao, Y., Fang, P., Kim, S., Guo, M., Young, N. L., & Marshall, A. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181869 · Cited by 6
Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice
Morozko, E. L., Ochaba, J., Hernandez, S. J., Lau, A., Sanchez, I., Orellana, I., Kopan, L., Crapser, J. D., Duong, J. H., Overman, J., et al. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-180329 · Cited by 6
“Soluble oligomers can go on to form spherical prefibrillar or protofibrilar soluble oligomers [14] before maturing into amyloid-like aggregates [15] and fibrils [16].”
Front Cover: Analysis of the degradation of amyloid beta fibrils after separation via the combination of non‐denaturing agarose electrophoresis and Congo red dye staining
Kawano, R., Nakanishi, A., Zako, T., & Shimazaki, Y. (2019) · Separation Science Plus · doi:10.1002/sscp.201900049 · Cited by 3
Neuronal chloride transporters in neurodegenerative diseases
Yang, L., & Justice, N. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815318-5.00023-6 · Cited by 6
Exploring Proteins Containing Amyloidogenic Regions in the Proteomes of Bacteria of the Order Rhizobiales
Antonets, K., Kliver, S., & Nizhnikov, A. (2018) · Evolutionary bioinformatics online · doi:10.1177/1176934318768781 · Cited by 6
The heat shock response, determined by QuantiGene multiplex, is impaired in HD mouse models and not caused by HSF1 reduction
Gomez-Paredes, C., Mason, M. A., Taxy, B. A., Papadopoulou, A. S., Paganetti, P., & Bates, G. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-88715-5 · Cited by 6
Self-citation
Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins
Rahimi, F., & Bitan, G. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_1 · Cited by 6
Dominantly inherited ataxias. Part I
Storey, E. (1998) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(98)90059-5 · Cited by 6
Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake
Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4

Authors: Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E.
Affiliations: Max Planck Institute for Molecular Genetics (DE)
University College London (GB)
Guy's Hospital (GB)
Corresponding author: Wanker, Erich E
ORCID: Bates, Gillian P
Wanker, Erich E
Venue: Cell
Publisher: Elsevier BV
Published: 1997-08
Volume: 90
Issue: 3
Pages: 549-558
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)80514-0
OpenAlex: W2079250951
Cited by: 1,291
References: 42
Citations by year: 2026: 17 · 2025: 31 · 2024: 23 · 2023: 23 · 2022: 24 · 2021: 37 · 2020: 55 · 2019: 44 · 2018: 49 · 2017: 43 · 2016: 34 · 2015: 32 · 2014: 43 · 2013: 38 · 2012: 52
FWCI: 25.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5829 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, polyglutamine expansion, huntingtin, protein aggregation, amyloid-like aggregates, proteolytic cleavage, GST fusion protein, neurodegeneration, transgenic mouse model, fibril morphology, amyloid-beta
MeSH terms: Huntingtin Protein, Amino Acid Sequence, Amyloid, Animals, Base Sequence, Brain, Cell Nucleus, Exons, Glutathione Transferase, Humans, Huntington Disease, Kidney, Mice, Transgenic, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Recombinant Fusion Proteins, Polymerase Chain Reaction, DNA Primers, Macromolecular Substances, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks